FDA notifications. FDA grants tentative approval to generic Nevirapine.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D019829:Nevirapine; D018894:Reverse Transcriptase Inhibitors; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine